Figure 1From: Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinomaKaplan-Meier survival curve. Median survival time for all patients treated is 28.6 months. For stage III patients, the median survival time was not reached, but estimated at 34.7 months.Back to article page